News | Cardiovascular Clinical Studies | July 22, 2020

Eating Chocolate Once a Week May Reduce Risk of Heart Disease

New study shows evidence chocolate is good for the heart

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

Hershey's Chocolate display with samples and coco pods at the American College of Cardiology (ACC) 2012 annual meeting. The company was making the case that chocolate can be good for your heart, which is now supported by several studies. Photo by Dave Fornell

July 22, 2020 — Eating chocolate at least once a week is linked with a reduced risk of heart disease, according to research published today in the European Journal of Preventive Cardiology, a journal of the European Society of Cardiology (ESC).[1] 

“Our study suggests that chocolate helps keep the heart’s blood vessels healthy,” said study author Chayakrit Krittanawong, M.D., of Baylor College of Medicine, Houston, Texas.

“In the past, clinical studies have shown that chocolate is beneficial for both blood pressure and the lining of blood vessels,” he continued. “I wanted to see if it affects the blood vessels supplying the heart (the coronary arteries) or not. And if it does, is it beneficial or harmful?”

The researchers conducted a combined analysis of studies from the past five decades examining the association between chocolate consumption and coronary artery disease (the blockage of the coronary arteries). The analysis included six studies with a total of 336,289 participants who reported their chocolate consumption.

During a median follow-up of nearly nine years, 14,043 participants developed coronary artery disease and 4,667 had a heart attack (when coronary artery disease progresses and the flow of blood to the heart is suddenly blocked).

Compared with consuming chocolate less than once a week, eating chocolate more than once a week was associated with an 8 percent decreased risk of coronary artery disease.

“Chocolate contains heart healthy nutrients such as flavonoids, methylxanthines, polyphenols and stearic acid which may reduce inflammation and increase good cholesterol (high-density lipoprotein or HDL cholesterol),” Krittanawong said.

He noted that the study did not examine whether any particular type of chocolate is more beneficial and whether there is an ideal portion size. “Chocolate appears promising for prevention of coronary artery disease, but more research is needed to pinpoint how much and what kind of chocolate could be recommended,” he said.

While it is not clear how much chocolate is optimal, Krittanawong warned against overeating. “Moderate  amounts of chocolate seem to protect the coronary arteries but it’s likely that large quantities do not. The calories, sugar, milk, and fat in commercially available products need to be considered, particularly in diabetics and obese people,” he explained.

 

Related Content of Chocolate and Heart Health:

Swedish Study Shows Chocolate May Prevent Stroke

Moderate Chocolate Consumption Linked to Lower Heart Failure Risk

New Study Finds Eating Chocolate Regularly Could Cut Cardiovascular Risk by One Third

Cocoa, Chocolate May Repair Blood Vessels, Increase Blood Flow

Dark Chocolate May Help Lower Risk of Heart Attack

Editor’s Choice for Most Innovative Technology at ACC 2012

Regular Caffeine Consumption Does Not Result in Extra Heartbeats

 

Reference:

1. Krittanawong C, Narasimhan B, Wang Z, et al. Association between chocolate consumption and risk of coronary artery disease: a systematic review and meta-analysis. Eur J Prev Cardiol. 2020. doi:10.1177/2047487320936787.

 

Related Content

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

The first 3-D images have been created of an RNA molecule known as "Braveheart" for its role in transforming stem cells into heart cells. Credit: Image courtesy Los Alamos National Laboratory

News | Cardiovascular Clinical Studies | January 20, 2020
January 20, 2020 — Scientists at Los Alamos and international partners have created the first 3-D images of a special
Top Cardiology New in 2019 From the European Society of Cardioloigy (ESC)
News | Cardiovascular Clinical Studies | December 23, 2019
Environmental and lifestyle issues were popular this year, with pick up from both...
News | Cardiovascular Clinical Studies | November 26, 2019
November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have sele
FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo